ClearPoint Neuro (CLPT) Other Working Capital Changes (2011 - 2026)
ClearPoint Neuro (CLPT) reported Other Working Capital Changes of $172000.0 for Q1 2026, up 129.6% on a YoY basis from $74911.5 in Q1 2025, and up 158.11% sequentially from -$296000.0 in Q4 2025.
ClearPoint Neuro (CLPT) Other Working Capital Changes (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 7 years of Other Working Capital Changes data on file, last reported at $172000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 129.6% year-over-year to $172000.0; the trailing twelve-month figure through Mar 2026 stood at -$259000.0 (up 79.75% YoY), and the FY2025 full-year result was -$1.0 million, down 16.46% from the prior year.
- Other Working Capital Changes improved to $172000.0 in Q1 2026, from -$296000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.2 million in Q3 2022 to a low of -$653000.0 in Q1 2026.
- A 5-year average of -$14187.5 and a median of -$97500.0 in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 482.31% in 2024, while the deepest fall reached 891.84% in 2024.
- Tracing CLPT's Other Working Capital Changes over 5 years: stood at -$141000.0 in 2022, then tumbled by 43.26% to -$202000.0 in 2023, then decreased by 15.84% to -$234000.0 in 2024, then declined by 26.5% to -$296000.0 in 2025, then surged by 158.11% to $172000.0 in 2026.
- Business Quant data shows CLPT's Other Working Capital Changes at $172000.0 in Q1 2026, -$296000.0 in Q4 2025, and -$140000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -653,000.00 |
| Mar 31, 2026 | -653,000.00 |
| Mar 31, 2026 | -653,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Sep 30, 2025 | 56,000.00 |
| Jun 30, 2025 | 304,000.00 |
| Jun 30, 2025 | 304,000.00 |
| Jun 30, 2025 | 304,000.00 |
| Mar 31, 2025 | -168,000.00 |
| Mar 31, 2025 | -168,000.00 |
| Mar 31, 2025 | -168,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Sep 30, 2024 | -382,000.00 |
| Sep 30, 2024 | -382,000.00 |